Curis
CRIS
#11006
Rank
A$0.96 M
Marketcap
A$0.49
Share price
-17.89%
Change (1 day)
-81.36%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): A-$34.90

According to Curis's latest financial reports the company's current EPS (TTM) is A-$33.97. In 2025 the company made an earnings per share (EPS) of A-$33.97 an increase over its 2024 EPS that were of A-$200.69.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$34.902.72%
2025A-$33.97-83.07%
2024A-$200.69-22.15%
2023A-$257.79-26.17%
2022A-$349.1422.3%
2021A-$285.48-25.37%
2020A-$382.54-30.93%
2019A-$553.83-2.02%
2018A-$565.25
2016A-$1,285-10%
2015A-$1,427138.1%
2014A-$599.5140%
2013A-$428.22-25%
2012A-$570.9666.67%
2011A-$342.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.87-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$5.08-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.51-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$4.47-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.08-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$7.19-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$0.24-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA